Navigation Links
Philips and PathAI team up to improve breast cancer diagnosis using artificial intelligence technology in 'big data' pathology research
Date:3/29/2017

AMSTERDAM, March 29, 2017 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and PathAI, a company that develops artificial intelligence technology for pathology, are collaborating with the aim to develop solutions that improve the precision and accuracy of routine diagnosis of cancer and other diseases. The partnership aims to build deep learning applications in computational pathology, enabling this form of artificial intelligence to be applied to massive pathology data sets to better inform diagnostic and treatment decisions. The initial focus of this effort is on developing applications to automatically detect and quantify cancerous lesions in breast cancer tissue.

The accurate quantitative assessment of cancer involvement and scale is a central and challenging task for pathologists. This task, while critical to diagnosis and treatment, is very time-consuming and can place increased pressure on pathologists to conduct slide readings and analysis faster. Historically, pathologists have manually reviewed and analyzed tumor tissue slides using a microscope, but the rising shortage of pathologists and the increase in cancer caseloads1,2 require digital pathology solutions and smart image analysis software that reduce pathologists' routine workload, improve diagnostic accuracy and precision, and reduce error rates.

Continue Reading
Philips and PathAI aim to build deep learning applications in computational pathology to better inform diagnostic and treatment decisions.
Philips and PathAI aim to build deep learning applications in computational pathology to better inform diagnostic and treatment decisions.

"Breast cancer is the most common cancer in women worldwide, with over 250,000 new cases3 diagnosed every year in the U.S.," says Andy Beck, CEO of PathAI. "Our goal is to help patients receive fast, accurate diagnosis and support treating physicians to deliver optimal care by empowering pathologists with decision support tools powered by artificial intelligence. For example, identifying the presence or absence of cancer in lymph nodes is a routine and critically important task for a pathologist. However, it can be extremely laborious using conventional methods. Research indicates that pathologists supported with computational tools could be both more accurate and faster."

Deep learning is an algorithmic technique that is revolutionizing what is possible in areas such as finance, communication, automotive, natural language processing, computer vision and more. It allows computers to analyze vast amounts of data and automatically detect patterns and make accurate predictions. Philips has already implemented deep learning in its clinical informatics solutions for radiology such as Illumeo and IntelliSpace Portal 9.0. With the proliferation of digital pathology and whole slide imaging (WSI), computers will soon be able to learn and unlock the 'big data' potential of thousands of digital tumor tissue (histology) images and related patient data. As a pioneer in the digitization of pathology, Philips has created a leading digital pathology business through strategic investments, partnerships and technology licenses.

"Digitizing images in pathology has the potential to transform the field by unlocking new opportunities in image recognition," said Russ Granzow, General Manager of Philips Digital Pathology Solutions. "With computational pathology and the application of artificial intelligence there is an opportunity to increase efficiencies, enable greater accuracy and precision, and allow pathologists to see things and access insights not previously available."

Last year, Dr. Andy Beck and his colleagues from Harvard Medical School and MIT, won a global challenge on the detection of metastatic lesions in lymph nodes with a performance that rivals human error rates consistently. Now Philips and PathAI are partnering to ensure such highly promising technologies could find a practical application in aiding pathologists in their effort to deliver high quality, high confidence diagnosis.

1 The Royal College of Pathologists, https://www.rcpath.org/profession/workforce/workforce-planning.html, Accessed December 2016.,
2 International Agency for Research on Cancer and Cancer Research UK. World Cancer Factsheet. Cancer Research UK, London, 2014.
3 www.breastcancer.org

For further information, please contact:

Hans Driessen
Philips Digital Pathology Solutions
Tel: +31 6 1061 0417
E-mail: hans.driessen@philips.com

Steve Klink
Philips Group Press Office
Tel. : +31 6 1088 8824
E-mail: steve.klink@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 71,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/philips-and-pathai-team-up-to-improve-breast-cancer-diagnosis-using-artificial-intelligence-technology-in-big-data-pathology-research-300430598.html


'/>"/>
SOURCE Royal Philips
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Philips expands its award-winning DreamStation platform to treat patients with most complex sleep and breathing needs
2. Philips receives FDA 510(k) clearance to market its ElastQ Imaging shear wave elastography for non-invasive assessment of tissue stiffness of the liver
3. Philips spotlights connected technology, predictive analytics software, and artificial intelligence advancing population health and precision medicine at HIMSS 2017
4. Research and Markets - Global Ultrasound Device Market - Analysis, Technologies & Forecast to 2022 - Key Players are Siemens, Philips & Hitachi Ltd.
5. Research and Markets - Global Intravascular Ultrasound Market Growth at 6.56%, 2016-2020: Key Vendors are Philips Volcano, Boston Scientific, GE Healthcare & Siemens Healthineers
6. Philips enhances neurological diagnosis with the introduction of IntelliSpace Portal 9.0(1)
7. Philips introduces new data-driven intelligent solutions connecting patients, practitioners and processes at the 2016 Radiological Society of North America Meeting
8. Philips is first to bring adaptive intelligence to radiology, delivering a new approach to how radiologists see, seek and share patient information
9. Philips announces commercial availability of its interoperable and scalable IntelliSpace Universal Data Manager for healthcare enterprises
10. Philips introduces DoseWise Portal 2.2, next generation dose management software solution at RSNA 2016
11. Philips präsentiert innovative Kardiologie-Lösungen mit einmaligen interaktiven Virtuelle-Realität-Erfahrungen auf jährlichem Kongress EuroPCR 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of ... to be in the beginning stages of an IPO. ... epilepsy medications with the average cost of a prescription epilepsy drug being ... AXIUM ... Another staggering figure is the fact that ...
(Date:8/10/2017)... Colo. , Aug. 10, 2017  Physical Rehabilitation Network ... located in Lakewood, Colorado . The reputable ... Jeff Lipkin , PT, DPT with his staff of four ... University of Pittsburgh and brings over 10 years of experience ... Belmar PT marks the 10th PRN clinic in ...
(Date:8/7/2017)... , Aug. 7, 2017 Diplomat Pharmacy, Inc. ... Joel Saban as president, effective Aug. 7, 2017. ... has decided to pursue other interests and will serve ... his tenure, Paul has served us in multiple leadership roles ... Pharmacy in Jun. 2015 and has provided decisive, strategic leadership ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... Inc. magazine has ranked American Specialty Health, ... of the nation's fastest-growing private companies. This marks the eighth time in the last ... . This year’s ranking reflects ASH’s 76 percent overall revenue growth from 2013 ($239 ...
(Date:8/18/2017)... ... 2017 , ... “Dangerous Inheritance”: a mystery about saving the family farm. ... Southwest Nebraska where she was raised on a farm. As Diane wrote this ... but the friendships and mantra of ‘neighbors helping neighbors’ have always been a large ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Depressed: Super Heroes of the Bible”: ... upon the stories and the relevance these tales may have on the reader’s life. ... a former special education teacher, Jessica spends much of her time enjoying nature and ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Prompted By Love”: a love story thrown ... author, Mary Nettles. Author Mary P. Nettles has devoted her life to ministry ... Her lifelong desire to write was, however, not fulfilled until 2014 when "The ...
(Date:8/17/2017)... , ... August 17, 2017 , ... ... is adding a new location in Goldsboro, NC to its family of practices. ... is Riccobene Associates’ trademark starting August 15, 2017. , Riccobene Associates Family ...
Breaking Medicine News(10 mins):